About
Contact & Profiles
A5102753536
Research Areas
- Immunodeficiency and Autoimmune Disorders
- Immune responses and vaccinations
- Tuberculosis Research and Epidemiology
TuBerculosis Vaccine Initiative
2020
Two proof of concept clinical trials with TB vaccines demonstrate that new approaches can prevent sustained infection in adolescents (BCG revaccination) and disease adults (M72/ASO1E) (Nemes et al., 2018; Tait 2019) [1,2]. Both are late stage development provide motivation rationale to invest into a global vaccine pipeline. This pipeline needs be diverse address TB-specific challenges including variation target populations, uncertainties animal model predictivity lack immune correlates...
10.1016/j.tube.2020.102040
article
EN
cc-by
Tuberculosis
2020-12-08
Coming Soon ...